The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration-Reference-Cited by-同舟云学术

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

Published:2024-05-07 Issue:6 Volume:47 Page:585-599
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Fusaroli Michele^ORCID,Salvo Francesco,Begaud Bernard,AlShammari Thamir M.,Bate Andrew,Battini Vera,Brueckner Andreas,Candore Gianmario,Carnovale Carla,Crisafulli Salvatore,Cutroneo Paola Maria,Dolladille Charles,Drici Milou-Daniel,Faillie Jean-Luc,Goldman Adam,Hauben Manfred,Herdeiro Maria Teresa,Mahaux Olivia,Manlik Katrin,Montastruc François,Noguchi Yoshihiro,Norén G. Niklas,Noseda Roberta,Onakpoya Igho J.,Pariente Antoine,Poluzzi Elisabetta,Salem Myriam,Sartori Daniele,Trinh Nhung T. H.,Tuccori Marco,van Hunsel Florence,van Puijenbroek Eugène,Raschi Emanuel,Khouri Charles

Funder

Alma Mater Studiorum - Università di Bologna

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40264-024-01423-7.pdf

Reference84 articles.

1. Raschi E, Moretti U, Salvo F, Pariente A, Antonazzo IC, Ponti FD, et al. Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety. Pharmacovigilance. 2018. Available at: https://www.intechopen.com/online-first/evolving-roles-of-spontaneous-reporting-systems-to-assess-and-monitor-drug-safety

2. Croteau D, Pinnow E, Wu E, Muñoz M, Bulatao I, Dal Pan G. Sources of evidence triggering and supporting safety-related labeling changes: a 10-year longitudinal assessment of 22 new molecular entities approved in 2008 by the US food and drug administration. Drug Saf. 2022;45:169–80.

3. Faillie J-L. Case-non-case studies: principle, methods, bias and interpretation. Therapie. 2019;74:225–32.

4. Insani WN, Pacurariu AC, Mantel-Teeuwisse AK, Gross-Martirosyan L. Characteristics of drugs safety signals that predict safety related product information update. Pharmacoepidemiol Drug Saf. 2018;27:789–96.

5. Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med. 2016;14:10.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stratified analysis of the association between anti-obesity medications and digestive adverse events: a real-world study based on the FDA adverse event reporting system database;BMC Pharmacology and Toxicology;2024-09-12

2. Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature;Expert Opinion on Drug Safety;2024-09-11

4. A disproportionality analysis of sunitinib in the FDA adverse event reporting system (FAERS);Heliyon;2024-09

5. Peptic ulcers with ChEIs, NSAIDs;Journal of the American Geriatrics Society;2024-08-22